Full coverage· Health· Updated
Weekly Insulin Injection Approved for Sale in Israel
A new once-weekly insulin injection, Awiqli, is now available for private purchase in Israel, offering an alternative to daily shots for diabetes patients. The U.S. FDA approved it for adults and recently for children aged 10 and up with type 2 diabetes.
2 newsrooms · 2 languages · sincePlus
What happened
- 01Novo Nordisk's once-weekly insulin, Awiqli, is now sold privately in Israel.
- 02The U.S. FDA approved Awiqli for adults and recently for children aged 10+ with type 2 diabetes.
- 03Awiqli offers an alternative to daily insulin injections for diabetes management.
- 04Prices in Israel range from 280 to 527 shekels per package, lasting up to 12 weeks.
- 05The new insulin is not currently included in Israel's national health basket.
Prices in Israel range from 280 to 527 shekels per package, which can last up to 12 weeks, but it is not yet covered by the national health basket.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- CentreNone
- Right1
- HarediNone
- ArabNone
- Other1
How it broke
See which of the 2 newsrooms broke it, and who waited
